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Abstract
Background: The purpose of this study was to evaluate ultrasound-guided surgery for palpable breast cancer by
comparing the standard palpation-guided surgery in terms of the extent of healthy breast tissue resection, the
percentage of tumor-free margins, and cosmetic outcomes.
Methods: This was a prospective, observational cohort study conducted from January 2009 to July 2011. Breast
cancer patients, diagnosed via biopsy, were operated in guidance with either ultrasound or palpation. Patient
demographics, tumor features, intraoperative findings, pathologic and cosmetic results, intraoperative-measured
ultrasound margins, and pathology margins were compared.
Results: Ultrasound (US)-guided lumpectomy was performed on 84 women and palpation-guided lumpectomy on
80 women. Patient demographics and tumor characteristics showed no differences. The rate of re-excision was
17 % for the palpation-guided surgery group, and 6 % for the US-guided group (p = 0.03). There was good
correlation between the closest margins recorded by US and pathology margins (r = 0.76, p = 0.01). Volume of
resection was significantly larger in the palpation-guided group despite the similar size of tumors (p = 0.048).
Cosmetic outcome of surgery was equivalent between groups.
Conclusions: Intraoperative ultrasound guidance for excision of palpable breast cancers is feasible and gives results
in terms of pathologic margins that are comparable with those achieved by standard palpation-guided excisions.
Keywords: Ultrasound-guided lumpectomy, Intraoperative ultrasound, Positive margin, Re-excision rate
Background
With improvement in detection of breast cancer at an
earlier stage, more breast cancers are being detected at a
smaller size. This makes breast conservation surgery
(BCS) a feasible and preferred option for many women
diagnosed with early-stage breast cancer. Many women
choose to pursue BCS because of the improved cosmetic
and psychological outcome from breast preservation.
Local recurrence after BCS is related to patient age,
tumor size and grade, and presence of multifocal or
multicentric disease [1–3]. However, margin status is the
strongest predictor of local recurrence [3–6]. Although
local recurrence risk is reduced by wider tissue excision,
cosmetic results are adversely affected by more extensive
operations. Evaluation of the resection margins is com-
monly undertaken as an aid to achieve an optimal
balance between adequate local control and cosmetic re-
sults. Some authors reported cosmetic results after BCS
as unacceptable in up to 30 % of patients. The main fac-
tor determining the cosmetic result is resection volume.
If it is larger than 50–85 cm3, the cosmetic result is pur-
poseful to be a failure [7–12].
Several techniques have been suggested in order to
avoid inadequate margins in breast-conserving surgery
[4, 13]. These include gross examination of the lumpec-
tomy specimen, frozen section, touch prep analysis, in-
traoperative specimen radiography, and intraoperative
ultrasound (US) as well as newer investigational tools
[13–15]. There have been several groups who have pub-
lished their experiences with lumpectomy using the in-
traoperative US technique [7, 13, 16–22]. Intraoperative
US for palpable breast cancers not only facilitates clearer
margins with fewer additional treatment interventions
but also effects decision-making by achieving optimum
resection volume which end up with good cosmetic
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results. US guidance offers some benefits over needle
localization guidance in terms of non-palpable breast
cancer. US guidance provides better operational anat-
omy coordination which causes a surgeon to end up
with better margin clearance and less re-excision rates
and also better cosmetic outcomes. Palpable breast can-
cer patients should benefit from US-guided lumpectomy
as it was reported for non-palpable breast cancer pa-
tients as the surgeons reduces the rate of positive mar-
gins. Some studies were reported to have better surgical
accuracy in the guidance of US than palpation for palp-
able breast cancers [7, 13, 23].
We hypothesized that intraoperative US would confer
upon the surgeon a greater ability to discern the precise
margins of the tumor. This would enable a more fitting
initial excisional diameter and fewer close positive
margins, thereby reducing the need for subsequent
interventions. Furthermore, we hypothesized that other
benefits accrued by use of intraoperative US include
minimization of normal breast parenchyma resection




This was an institutional review board-approved, pro-
spective, observational cohort study conducted from
January 2009 to July 2011. Beginning in June 2010, US
technology which was not available before became avail-
able in our operating room. We prospectively evaluated
84 consecutive patients undergoing US-guided lumpec-
tomy for a palpable breast cancer after June 2010. We
selected 80 consecutive palpable breast cancer patients
operated at our institution without any guidance tech-
nique before introduction of intraoperative US from our
data.
All patients in both groups were diagnosed via core bi-
opsy as having invasive breast cancer. All admitted
breast cancer patients’ data, findings and results are re-
corded at our institution. Patients who may have under-
gone subsequent mastectomy as a second operation
were not excluded from the initial analysis. Although pa-
tient allocation into either cohort was non-randomized,
we did include all eligible patients and do not believe
that there are any factors of significance that would bias
this sample. Patients who received neoadjuvant chemo-
therapy, diagnosed following previous excisional biopsy,
and patients with non-palpable tumors were excluded
from the study.
Surgery
Surgery was performed under general anesthesia by an
experienced oncological breast surgeon. The surgery
started with the axillary procedure. The sentinel node
was sent for frozen section study, and if metastasis was
diagnosed, axillary lymph node dissection was performed
during the same procedure. Node-positive patients who
were pre-operatively confirmed by US-guided fine-
needle aspiration biopsy underwent axillary lymph node
dissection. After the axillary procedure, surgery of the
breast was performed.
Palpation-guided surgery
In the palpation-guided surgery group, tumor excision
was guided by the palpation of the surgeon in the stand-
ard manner. The index finger was used to palpate the
mass, retract it, and guide the dissection. In this proced-
ure, the adequacy of the resection was based on the ex-
perience of the surgeon without objective imaging
during surgery. The aim of surgical excision was to ob-
tain a 1-cm rim of healthy adjacent breast tissue around
the malignant breast lesion. Tumor was excised in a cy-
lindrical manner with muscular fascia as posterior mar-
gin. At the time of operation, specimens were sent to
the pathology department for margin analysis but not to
the radiology department for specimen radiology. Intra-
operative re-excision was performed if the specimen
margin was reported to be positive or less than 5 mm
macroscopically. This is a routine margin approach pro-
cedure applied at our institution [24].
Ultrasound-guided surgery
Intraoperative localization was performed using a multi-
frequency 10-MHz linear array ultrasound probe. At the
beginning of the study, for the first ten procedures, an
experienced breast radiologist was present and assisted
the procedure in the operating room. Later on, our ex-
perience developed, and a radiologist’s assistance was
not required.
Tumor localization of was done after probe’s midpoint
is placed transversely just over the tumor center. The
probe’s ends were marked over the skin. These two spots
were connected with a line. Later, the procedure was re-
peated in sagittal direction. Little pressure was used to
avoid tissue displacement. Planed surgical incision and
extent of the planed excision tissue with a 1-cm clear
border away from the tumor was marked as well. The
provided information by the US for the depth of the
tumor from skin and distance to muscular layer was
used to estimate flaps thickness (Fig. 1).
After marked skin incision, skin flaps were prepared
till the previously marked tissue excision border (Fig. 2).
The tumor was confirmed via US to still be in the exci-
sion border with clear margins (Fig. 3). Then, tissue was
excised in a cylindrical manner perpendicularly to the
chest wall (Fig. 4). Posterior adequate margin was deep
enough to the muscular fascia even containing the fascia
itself. Then, specimen margins were marked, and ex vivo
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US were performed to determine tumor-free margins
(Fig. 5). If a margin less than or equal to 5 mm was de-
tected, a re-excision of that area was performed.
Direct volume measurements were performed by using
a water displacement technique undertaken by the same
team member (breast care nurse) in the operating room
on each occasion which is performed as a standard pro-
cedure due to ongoing studies since 2008. The excised
breast tissue was placed in a cylinder of known volume.
The specimen was then submerged in the cylinder,
and the volume of the displaced water was measured.
The validity and reproducibility of this method was
confirmed by submerging breast implants of known
volume into the cylinder and assessing the water vol-
ume displaced.
After specimen fixation in formalin solution, all speci-
mens were evaluated for tumor size in length, width,
and height using a millimeter ruler and microscopic
margin status by histopathologic evaluation of perman-
ent sections. Tumor volume was calculated using length
× width × height formula. The closest margin of excision
was measured and documented. Any patients with
microscopically positive margins (tumor cells present at
an inked margin) were re-excised in a second operative
procedure.
Data analysis
Demographic, clinical, and pathological data including
age, body mass index (BMI), menopausal status, tumor
localization, histopathologic type, T and N stage, grade
(Scarf-Bloom-Richardson), the presence of intraductal
component, lymphovascular invasion and necrosis, and
receptor status (ER, PR, HER2-neu) were gathered. In-
traoperative data including length of surgery, ultrasound
findings, and the rate of intraoperative re-excision were
Fig. 1 Intraoperative tumor localization by ultrasound
Fig. 2 Ultrasound image of the tumor
Fig. 3 Marking of the tumor
Fig. 4 Excised and oriented tumor
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recorded. For cosmetic evaluation, patients and/or pa-
tients’ pictures were re-evaluated at 6 months postopera-
tively and classified by two clinicians. These clinicians
were not informed of the patients’ therapeutic proced-
ure, and they used the four category scale: excellent,
good, fair and poor according to the Harvard Cosmetic
Scale [25].
Microsoft Excel software (Microsoft Luxembourg
S.a.r.l., 20 Rue Eugene Ruppert, Luxembourg) was used
to record the data. Comparisons between continuous
variables were analyzed using the t test or Mann-
Whitney U test. Comparisons between categorical vari-
ables were based on Pearson’s chi-square test of Fisher’s
exact test. Pearson’s correlation coefficient was used to
assess the correlation between the US findings and mar-
gin width. In all statistical analyses, a p value of <0.05
was considered significant. Data analysis was carried out
with the Statistical Package for Social Sciences (SPSS)
version 15.0 (SPSS, Chicago, IL, USA).
Results
The study was designed in two groups for palpable
breast cancer, US-guided lumpectomy group and
palpation-guided lumpectomy group which consisted of
consecutive 84 and 80 patients, respectively. Patient and
tumor characteristics are listed in Table 1. None of the
screening items exhibited differences between the two
groups.
The re-excision rates were not statistically significant
in the US-guided group between the first, second, third,
and fourth quartile of patients. Positive margins were
observed in five (6 %) of the patients in the US-guided
group and 14 (17 %) of the patients in the palpation-
guided group (p = 0.03). Three (60 %) patients’ re-
excision specimens were reported to have residual ductal
carcinoma in situ or invasive ductal carcinoma and two
(40 %) patients’ re-excision specimens had only post-
operative changes without any residual atypia or malig-
nancy in the US-guided group. Seven (50 %) patients
had residual ductal carcinoma in situ or invasive ductal
carcinoma out of 14 patients undergoing re-excision in
Fig. 5 Ex vivo ultrasound of the tumor
Table 1 Comparison of patient and tumor characteristics






Age, mean (SD), y 51.1 (12.8) 53.4 (13.3) 0.25
Body mass index, mean (SD) 25.2 (4.5) 25.1 (3.5) 0.8
Menopausal status
Premenopausal 37 (46 %) 30 (36 %)
Postmenopausal 43 (54 %) 54 (64 %) 0.2
Tumor location
Outer 59 (74 %) 56 (67 %)
Inner 21 (26 %) 28 (33 %) 0.39
Tumor size
1–10 mm 6 (7 %) 11 (13 %)
11–20 mm 31 (39 %) 29 (35 %)
>20 mm 43 (54 %) 44 (52 %) 0.26
Lymph node status
Negative 49 (61 %) 54 (64 %)
Positive 31 (39 %) 30 (36 %) 0.74
Grade
1 12 (15 %) 10 (12 %)
2 36 (45 %) 44 (52 %)
3 32 (40 %) 30 (36 %) 0.62
EICa
Yes 26 (33 %) 22 (26 %)
No 54 (67 %) 62 (74 %) 0.39
Lymphovascular invasion
Yes 45 (56 %) 50 (60 %)
No 35 (44 %) 34 (40 %) 0.75
Multifocality
Yes 17 (21 %) 11 (13 %)
No 63 (79 %) 73 (87 %) 0.21
ER
Positive 64 (80 %) 73 (87 %)
Negative 16 (20 %) 11 (13 %) 0.29
PR
Positive 54 (67 %) 65 (77 %)
Negative 26 (33 %) 19 (23 %) 0.17
HER2-neu status
Amplified 15 (19 %) 15 (18 %)
Nonamplified 65 (81 %) 69 (82 %) 0.88
EIC extensive intraductal component
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the palpation-guided group. Residual disease rate in the
re-excision pathology was not statistically different be-
tween two groups (p = 0.9), (Table 2).
Shaving rates (intraoperative re-excision) of the US-
guided lumpectomy group was 29 % due to close margins
on US of the lumpectomy specimen. The palpation-
guided surgery group exhibited a higher frequency (37 %)
of shaving rates (p = 0.25). Among patients that under-
went additional shave margins, seven within the US-
guided group (29 %) were spared additional surgery
thanks to more precise discernment capabilities provided
by the US apparatus. Under normal conditions, due to the
close or positive margins on the lumpectomy specimen,
these seven patients would have been required to undergo
additional surgery. This included two patients with mar-
gins of 3–4 mm, three patients with margins of ≤2 mm,
and two patients with involved margins according to the
specimen ultrasonography. The significant correlation be-
tween US findings and margin positivity can be seen in
Table 3 (r = 0.76, p = 0.01).
The tumor size was 2.5 ± 1.2 cm for palpation-guided
lumpectomy versus 2.3 ± 1.1 cm for the US-guided
lumpectomy group (p = 0.24). Comparing resection vol-
ume with calculations from the detailed post-operative
pathology reports and volume measurements, we found
that the volume of resection was significantly larger in
the palpation-guided group despite the similar size of
tumor (p = 0.048). The tumor/specimen volume in the
palpation-guided and US-guided lumpectomy groups
was 0.09 and 0.097, respectively. Also, tumor/specimen +
re-excision volume was not different between two groups
(p > 0.05). Cosmetic outcome of surgery was equivalent
between groups (p = 0.79).Of the 60 patients, 55 (92 %) in
the palpation-guided lumpectomy group and 67 of 71 pa-
tients (94 %) in the US-guided group have a post-
operative cosmetic rating of good or excellent.
Discussion
Because of the numerous disadvantages of needle
localization, several authors investigated the use of intra-
operative US in an effort to avoid the use of needle
localization of non-palpable breast lesions [26–29].
Some authors reported that US-guided excision of non-
palpable breast masses is practicable and even superior
to needle localization excision [7, 13, 16, 17, 20, 22].
Rahusen et al. [19] prospectively evaluated 19 patients
with 20 mammographically nonpapable lesions. They
used a 10-MHz transducer during surgery to localize the
tumor and plan the excision. They then compared their
experience with 43 wire localization excisions performed
during the same period. In the wire excision group, only
17 of 43 (40 %) resections were deemed to have
“adequate margins”. In the excisions using ultrasound
guidance, 17 (89 %) had acceptable margins. Similarly, in
their small randomized study, they recruited 49 patients,
and negative margins were reported in 89 % of the US-
guided excisions compared with 55 % of the needle
localization-guided excisions [16]. They found an advan-
tage in US-guided excision for obtaining adequate
margins in their studies. They were assisted with an ex-
perienced radiologist in the operating room. In addition
to positive margin rates, some drawbacks have been re-
ported with needle localization, including miss rates of
0–22 %, wire transection, dislocation, or migration, and
scheduling difficulties. Also, the patient may experience
the anxiety and discomfort of having a needle/wire in
the breast while awaiting the surgical procedure. Vaso-
vagal reactions also have been reported in approximately
20 % of cases [30, 31]. Krekel and colleagues [32] also
demonstrated a reduced level of involved margins in
Table 2 Comparisons of main pathological outcome measures







Tumor size, mean (SD) 24.9 (12.2) 22.8 (10.8) 0.24
Resection volume at first
excision, cubic centimeter,
(SD)
108.1 (63.4) 89.9 (53.9) 0.048
Intraoperative re-excision
Yes 30 (37 %) 24 (29 %)
No 50 (63 %) 60 (71 %) 0.25
Need for second operation to
achieve adequate margins
Yes 14 (17 %) 5 (6 %)




Yes 5 (17 %) 7 (29 %)
No 25 (83 %) 17 (71 %) 0.33
Tumor identified at second
operation specimen
Yes 7 (50 %) 3 (60 %)
No 7 (50 %) 2 (40 %) 0.9
Table 3 Correlation between US findings and pathological
margin involvement in US-guided lumpectomy group
(r = 0.76, p = 0.01)




Adequate margins (≥5 mm) 60 4 (7 %)
Close margins (3–4 mm) 12 2 (17 %)
Minimally involved margins (≤2 mm) 8 3 (38 %)
Involved margins 4 2 (50 %)
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their multicenter, randomized, and controlled study de-
signed for US-guided surgery versus palpation-guided
surgery in palpable breast cancer patients. Of the 65 pa-
tients, 2 (3 %) patients allocating ultrasound-guided
surgery had tumor-involved margins compared with 12
(17 %) of the 69 patients who were assigned palpation-
guided surgery (difference 14 %, 95 % CI 4–25; p =
0.0093). Seven (11 %) patients who received US-guided
surgery and 19 (28 %) of those who received palpation-
guided surgery required additional treatment (p = 0.015).
Compared with palpation-guided surgery, ultrasound-
guided surgery can significantly lower the proportion of
tumor-involved resection margins, thus reducing the need
for re-excision, mastectomy, and radiotherapy boost. They
stated that optimum resection volumes influence unneces-
sary resection and could contribute to improved cosmetic
results and quality of life.
The technique of US guidance for palpable masses is
mentioned in the literature. Many surgeons may feel
halfhearted to use US for a procedure instead of their
palpation senses. This could be due to unwillingness in
practical terms or due to unavailability. Krekel [33]
stated that skilled surgeons can gain the expertise
needed to do US-guided surgery in a fairly short training
period of up to eight procedures. Intraoperative US was
not available in our operating theater either until 2010.
Palpable lesions are reported to be associated with
higher margin positivity rates than non-palpable lesions,
so US should be more promising with palpable lesions.
Despite this, there are few publications on US-guided
breast-conserving surgery in the literature. In the ran-
domized study of Moore et al. [23], they compared 27
patients undergoing US guidance and 24 patients under-
going palpation guidance for palpable breast cancers.
They found that the rate of positive margins was signifi-
cantly less for the US-guided group (3 %) compared with
the palpation-guided group (29 %). They stated that US
guidance resulted in a decreased re-excision rate and im-
proved cosmesis. In our study, adequate resection was
performed on 94 % of patients in the US-guided surgery
group and on 83 % of patients in the palpation-guided
group (p = 0.03). Ultrasound correctly identified the clos-
est pathology margin in 85 % of patients. We accepted
tumor cells at an inked margin to perform re-excision at
a second operative procedure. However, the intention
was usually to achieve a 1-cm margin by ultrasound, and
intraoperative re-excision of the surgical cavity was car-
ried out for ultrasound margins of <5 mm in every case.
Another technique for evaluation of surgical margins
is intraoperative specimen radiography. If microcalcifica-
tions occur close to the edges of the specimen, the
associated cavity edges may be shaved to remove any re-
sidual malignant disease. Specimen radiography is found
to be reliable in identifying clear margins (74 % positive
predictive value) and reduces the rate of reintervention
from 31 to 20 % [34]. However, the use of radiographic
X-ray mammography is limited due to limitations in de-
tecting small, noncalcified lesions and a high rate of
nonspecific findings [35]. Lee and Carter [36] examined
postexcision specimen radiographs of 125 patients and
found sensitivity for detecting margin positivity as 49 %.
They concluded that intraoperative specimen radiog-
raphy could not be relied on solely but presents a valu-
able addition to BCS. We did not perform specimen
radiology because we investigated the value of intraoper-
ative US impact on reducing the marginal positivity sta-
tus alone. Further studies may be designed to compare
both techniques.
On the other hand, ultrasound overestimated the path-
ology margins in most cases. Margin overestimation by
ultrasound may lead the surgeon to incorrectly believe
that the excised margins are inappropriate. The overesti-
mation of the majority of the tumor margins may be
explained in part by the tendency of ultrasound to
underestimate the pathologic tumor diameter [28]. An-
other possible factor that needs to be taken into account
as a cause for overestimation of tumor margins by ultra-
sound is the compression of the specimen by the ultra-
sound probe during ex vivo examination of the margins.
The axial margins are then further away from the less
compressible tumor. This suggests that we cannot rely
solely on ultrasound to determine the extent of resection
and that palpation may still play an important part in
margin assessment. However, a measured ultrasound
margin of ≥0.5 cm resulted in 93 % adequate margins
(Table 3). Increasing the threshold for re-resection could
theoretically improve the rate of adequate excisions, but
this would lead to a significant increase in re-excisions
in patients in whom the original lumpectomy will prove
to be pathologically adequate.
US guidance gives the advantage of resecting less nor-
mal tissue while maintaining the clear margins with both
palpable and non-palpable masses [7, 13, 22, 23]. Moore
et al. [23] found that the volume of the lumpectomy spe-
cimen for palpable infiltrating ductal carcinomas was
smaller in their US-guided group (104 cm3) versus their
palpation-guided group (114 cm3), with increased mean
clear margin width (7.6 versus 4.8 mm, respectively).
Also Krekel et al. [32] reported that US-guided surgery
resulted in smaller excision volumes compared to
palpation-guided surgery in palpable breast cancer pa-
tients (38 versus 57 cm3; p = 0.002). Larger excisions
may lead to less margin positivity but may end up with
poor cosmesis. Our data show that US-guided lumpec-
tomy achieved good margins with a much smaller vol-
ume of resection compared with palpation-guided
surgery (mean resection volume, 89.9 versus 108.1 cm3,
respectively, p = 0.048). Since the tumor/specimen
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volume was nearly the same in both groups; attention
should be given on the point that intraoperative US can
significantly lower the rate of positive margins without
unnecessary tissue resection, not only on the resected
tissue amount. In our study, additional shave margins
were taken in nearly one-third of the patients undergo-
ing US-guided lumpectomy. Twenty-nine percent of
these patients who underwent intraoperative re-excision
according to the ultrasonographic findings have been
found to have a residual tumor in their cavity-shaving
specimen. Sonographic assessment in the operating
room provides appropriate assessment of all margins to
plan excision, and specimen ultrasonography can guide
immediately if a margin revision is indicated.
The same surgeon performed all lumpectomies. Al-
though we did not find any statistically significant differ-
ences in the re-excision rates between the first 20 and
last 20 cases, we experienced a learning curve at the be-
ginning due to a new procedure in use which was not
demonstrated by the re-excision data. Intraoperative and
specimen US provide useful information to the surgeon
for incision site and extension of margin shaving.
Conclusions
In conclusion, comparing complete tumor excision re-
sults between US-guided and palpation-guided lumpec-
tomy for palpable breast cancer US provides fair enough
or even better results. US also provides real-time
localization of palpable tumors leading to optimal inci-
sion and extent of excision. Intraoperative US may cause
reduction in terms of positive margins which may lead
to a reduction in need of margin-shaving rates and
tumor bed radiotherapy boost. Just as US has become a
standard tool of the breast surgeon’s office practice, we
propose a role for US in the accurate intraoperative as-
sessment of palpable breast tumors as well.
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